Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices.

Cannabix Technologies has entered a contract manufacturing agreement with Price Industries for its BreathLogix alcohol screening device product line. The company has been working with Price Electronics for months to qualify and establish manufacturing plans. The BreathLogix "Workplace Series" device was recently approved by the National Highway Traffic Safety Association in the US. Cannabix is also in discussions with US and Canadian manufacturers for its marijuana breath testing technology.

Cannabix Technologies Inc. (CSE: BLO) has announced a significant milestone in its manufacturing strategy by entering into a contract manufacturing agreement with Price Industries Ltd. for its BreathLogix alcohol screening device product line [2]. This agreement marks a crucial step in Cannabix's efforts to scale up production and expand its market reach.

Price Industries, with its 28,000 square foot facility in Winnipeg, holds ISO 13485, ISO9001, and IPC certifications, ensuring that the manufacturing process adheres to stringent quality standards. The company has been working with Price Electronics for months to qualify and establish manufacturing plans, reflecting Cannabix's commitment to reliability and precision in its product offerings.

The BreathLogix "Workplace Series" device recently received approval from the National Highway Traffic Safety Association (NHTSA) in the U.S. This approval was added to the U.S. Federal Register Conforming Products List for breath alcohol screen devices, further validating Cannabix's technological capabilities. The company has also secured an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd. for Australia, New Zealand, and Pacific Islands markets, expanding its geographical footprint.

In addition to these developments, Cannabix is actively engaging in discussions with U.S. and Canadian manufacturers regarding its marijuana breath testing technology. This includes its Breath Collection Unit, Breath Cartridge technology, and disposable parts, indicating a broader strategic approach to diversify its product portfolio.

The contract manufacturing agreement with Price Industries and the recent approval of the BreathLogix device are positive indicators for Cannabix, signaling the company's progress in commercializing its innovative technologies. As Cannabix continues to navigate the regulatory landscape and expand its market presence, investors and financial professionals should closely monitor these developments for potential future growth opportunities.

References:
[1] https://stockhouse.com/companies/bullboard?symbol=c.blo
[2] https://www.stocktitan.net/news/BLOZF/cannabix-technologies-enters-contract-manufacturing-agreement-with-tk7voheqy6uc.html